FSD Pharma Inc. (HUGE)

NASDAQ: HUGE · IEX Real-Time Price · USD
0.900
-0.022 (-2.43%)
At close: May 20, 2022 4:00 PM
0.930
0.030 (3.333%)
After-hours:May 20, 2022 7:50 PM EDT
Market Cap35.14M
Revenue (ttm)n/a
Net Income (ttm)-24.80M
Shares Out39.04M
EPS (ttm)-0.82
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume37,892
Open0.908
Previous Close0.922
Day's Range0.890 - 0.938
52-Week Range0.800 - 2.250
Beta0.98
AnalystsBuy
Price Target7.83 (+770.0%)
Earnings DateMay 13, 2022

About HUGE

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma In...

IndustryIT Services
Founded1998
CEORaza Bokhari
Employees10
Stock ExchangeNASDAQ
Ticker SymbolHUGE
Full Company Profile

Financial Performance

Financial numbers in millions CADFinancial Statements

Analyst Forecast

According to 7 analysts, the average rating for HUGE stock is "Buy." The 12-month stock price forecast is 7.83, which is an increase of 770.00% from the latest price.

Price Target
$7.83
(770.00% upside)
Analyst Consensus: Buy
Stock Forecasts

News

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

1 week ago - Business Wire

FSD Pharma Announces Dismissal of Derivative Complaint

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of...

2 weeks ago - Business Wire

FSD Pharma Announces Engagement with Tekkfund Capital and Share Issuance to Crystal Research Associates

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech ...

2 weeks ago - Business Wire

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

1 month ago - Business Wire

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

1 month ago - Business Wire

FSD Pharma Issues Corporate Updates

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

1 month ago - Business Wire

FSD Pharma Announces Filing of Year-End 2021 Results

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of...

1 month ago - Business Wire

FSD Pharma Announces Executive Informational Overview Report Produced by Crystal Research Associates LLC

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

2 months ago - Business Wire

FSD Pharma Announces Agreement for Sale of Cobourg Facility for CAD$16,500,000

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

2 months ago - Business Wire

FSD Pharma Announces Launch of New Corporate Website

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

4 months ago - Business Wire

FSD Pharma Congratulates Dr. Eleanor Fish on Being Named to the Order of Canada

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

4 months ago - Business Wire

FSD Pharma to Present at the H.C. Wainwright Bioconnect Conference on January 10-13th

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

4 months ago - Business Wire

FSD Pharma Announces Share Repurchase Program

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

4 months ago - Business Wire

FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D.

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

5 months ago - Business Wire

FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of...

5 months ago - Business Wire

FSD Pharma Unveils Videos Demonstrating Positive Effects of Lucid-MS in Treating Multiple Sclerosis in Pre-Clinical M...

TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of...

5 months ago - Business Wire

FSD Pharma Expands Research and Clinical Advisory Board with Appointment of World-Renowned Immunologist and Cytokine ...

TORONTO--(BUSINESS WIRE)---- $HUGE #RestoreFSD--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

6 months ago - Business Wire

FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH

TORONTO--(BUSINESS WIRE)---- $HUGE #RestoreFSD--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

7 months ago - Business Wire

FSD Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 13th

TORONTO, Oct. 13, 2021 /PRNewswire/ -- FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets ...

7 months ago - PRNewsWire

FSD Pharma Announces Engagement with Capital Markets Communications Providers and Market Maker

TORONTO--(BUSINESS WIRE)---- $HUGE #RestoreFSD--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

7 months ago - Business Wire

FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition

TORONTO--(BUSINESS WIRE)---- $HUGE #RestoreFSD--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio o...

8 months ago - Business Wire

Nasdaq-listed FSD Pharma To Advance Psychedelics Pipeline With $9 Million Acquisition Of Lucid Psycheceuticals

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE), a life sciences holding company looking at cannabinoid and psychedelic-based medicines, announced it is entering a definitive agreement to acquire Lucid Psychec...

8 months ago - Benzinga

FSD Pharma To Buy Canadian Psychedelic Pharmaceutical Firm

FSD Pharma Inc (NASDAQ: HUGE) shares rebounded after falling in premarket on acquiring a Canada-based psychedelic pharmaceutical company. Related:   See Why FSD Pharma Terminated COVID-19 Trial

8 months ago - Benzinga

FSD Pharma Announces Definitive Agreement to Acquire Lucid Psycheceuticals

Acquisition Advances Company's Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical Cannabis Acquisition Advances Company's Strategic Plan Toward a Diversified...

8 months ago - GlobeNewsWire

See Why FSD Pharma Terminated COVID-19 Trial

FSD Pharma Inc (NASDAQ: HUGE) will terminate the Phase 2 trial of ultra-micronized palmitoylethanolamide (PEA), or FSD-201, for COVID-19. FSD-201 works by stabilizing mast cells and down-regulates the p...

8 months ago - Benzinga